Back to BALYASNY ASSET MANAGEMENT L.P. BALYASNY ASSET MANAGEMENT L.P.

ESPRESPR
Showing 3 of 18 quarters

Position history for BALYASNY ASSET MANAGEMENT L.P.BALYASNY ASSET MANAGEMENT L.P.'s holdings in ESPERION THERAPEUTICS INC NE

BALYASNY ASSET MANAGEMENT L.P. holds 4.7M shares of ESPR (ESPERION THERAPEUTICS INC NE), worth $14.7M as of 2026-Q2. This is a new position. ESPR represents 0.0% of BALYASNY ASSET MANAGEMENT L.P.'s portfolio.

Current Value

$14.7M

Current Shares

4.7M

Total Value Change

+$14.4M

Total Shares Change

+4.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
4.7M
-
$14.7M0.0%$3.16
39
2025-Q4
Exited
0
-100.0%
$00.0%$3.69
0
2025-Q3
New
115,624
-
$306,4040.0%$2.64
32

Other major holders of ESPR: BNP PARIBAS FINANCIAL MARKETS, Pentwater Capital Management LP, WASATCH ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used